Targeting c‐Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma

E-ISSN： 1098-2299|76|7|357-367

ISSN： 0272-4391

Source： DRUG DEVELOPMENT RESEARCH, Vol.76, Iss.7, 2015-11, pp. : 357-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targeting of microRNAs in Cancer: Future Perspectives

DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. : 382-388

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNAs as a New Potential Therapeutic Opportunity in Gastrointestinal Cancer

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 75-89

Karger

Access to resources Recommend Favorite

Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks

HEPATOLOGY RESEARCH, Vol. 48, Iss. 1, 2018-01 ,pp. : 5-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNA‐494 is a master epigenetic regulator of multiple invasion‐suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 466-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exploiting the Therapeutic Potential of MicroRNAs in Viral Diseases: Expectations and Limitations

By > Ye Xin Thair Simone Yang Decheng

Molecular Diagnosis & Therapy, Vol. 14, Iss. 5, 2010-10 ,pp. : 271-282

Adis International

Access to resources Recommend Favorite